We measured tumor multiplicity at 22 weeks of age in Her2/neu transgenic mice with a germline deletion of one (Ptges+/–) or both (Ptges–/–) copies of the Ptges gene or in mice lacking both copies of Ptges in mammary epithelial cells only (Ptgesepi). Here, ERBB2 is linked to neoplasm.